We are live on
!
Find out more
WI
WBI Investments Portfolio holdings
AUM
$362M
1-Year Est. Return
23.75%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+23.75%
3 Year Est. Return
+74.43%
5 Year Est. Return
+103.13%
10 Year Est. Return
+415.98%
AUM
$637M
AUM Growth
-$24M
(-3.6%)
Cap. Flow
-$58.8M
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
50.2%
Holding
238
New
74
Increased
67
Reduced
34
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBI Power Factor High Dividend ETF
WBIY
|
+$11M |
| 2 |
AbbVie
ABBV
|
+$9.17M |
| 3 |
Raymond James Financial
RJF
|
+$7.15M |
| 4 |
Best Buy
BBY
|
+$6.25M |
| 5 |
Diamondback Energy
FANG
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBIE
WBI BullBear Rising Income 3000 ETF
WBIE
|
+$18.9M |
| 2 |
AstraZeneca
AZN
|
+$10.8M |
| 3 |
Novavax
NVAX
|
+$10.8M |
| 4 |
Pfizer
PFE
|
+$8.36M |
| 5 |
Bank of America
BAC
|
+$8.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.54% |
| 2 | Industrials | 7.51% |
| 3 | Technology | 6.76% |
| 4 | Consumer Staples | 5.74% |
| 5 | Healthcare | 3.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Pentair
PNR
$11B
| – | – |
-14,580
| Closed | -$774K |
|
227
Regions Financial
RF
$26.8B
| – | – |
-29,590
| Closed | -$477K |
|
228
Sherwin-Williams
SHW
$89.8B
| – | – |
-27,372
| Closed | -$6.71M |
|
229
Sarepta Therapeutics
SRPT
$1.77B
| – | – |
-10,064
| Closed | -$1.72M |
|
230
Teradyne
TER
$59.3B
| – | – |
-8,025
| Closed | -$962K |
|
231
TJX Companies
TJX
$178B
| – | – |
-58,306
| Closed | -$3.98M |
|
232
Travelers Companies
TRV
$80.2B
| – | – |
-21,956
| Closed | -$3.08M |
|
233
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| – | – |
-29,314
| Closed | -$2.85M |
|
234
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| – | – |
-43,031
| Closed | -$4.78M |
|
235
Valero Energy
VLO
$85.9B
| – | – |
-59,162
| Closed | -$3.35M |
|
236
Vistra
VST
$47.4B
| – | – |
-197,638
| Closed | -$3.89M |
|
|
WBA
237
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-45,725
| Closed | -$1.82M |
|
238
Webster Financial
WBS
$12.8B
| – | – |
-8,156
| Closed | -$344K |
|
Similar funds
MS
RC
VIA
HS
SIAG
WTFG
A6
ACM
WBI Investments's Q1 2021 Portfolio in Review
As of Q1 2021, WBI Investments held 238 positions worth $637M, down 3.6% from $661M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
WBI Investments withdrew a net $58.8M in Q1 2021, closing 63 positions and reducing 34 holdings. Its most notable exit was AstraZeneca, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Industrials and Technology.
Against the trend, WBI Investments opened a new position in Raymond James Financial worth $7.84M.
- WBI Investments's largest Q1 2021 buy was Raymond James Financial: 95,994 shares worth $7.84M.
- WBI Investments added most to WBI Power Factor High Dividend ETF in Q1 2021, an estimated $11M increase.
- WBI Investments's biggest Q1 2021 reduction was WBI BullBear Rising Income 3000 ETF, cutting an estimated $18.9M.
- WBI Investments fully exited AstraZeneca in Q1 2021, selling an estimated $10.8M.
- WBI Investments's ten largest holdings make up 50% of its $637M portfolio in Q1 2021.
- WBI Investments opened 74 new positions and closed 63 in Q1 2021.
- WBI Investments's portfolio value fell 3.6% quarter-over-quarter to $637M.
Based on WBI Investments's 13F filing for Q1 2021, filed 12 May 2021.